ES2058280T3 - (1',5'-diaril-3-pirazolil)-n-hidroxipropanamidas 2-y 3-sustituidas farmacologicamente activas y procedimiento para su sintesis. - Google Patents

(1',5'-diaril-3-pirazolil)-n-hidroxipropanamidas 2-y 3-sustituidas farmacologicamente activas y procedimiento para su sintesis.

Info

Publication number
ES2058280T3
ES2058280T3 ES88304821T ES88304821T ES2058280T3 ES 2058280 T3 ES2058280 T3 ES 2058280T3 ES 88304821 T ES88304821 T ES 88304821T ES 88304821 T ES88304821 T ES 88304821T ES 2058280 T3 ES2058280 T3 ES 2058280T3
Authority
ES
Spain
Prior art keywords
substituted
hidroxipropanamidas
pirazolil
diaril
synthesis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88304821T
Other languages
English (en)
Inventor
William V Murray
Michael P Wachter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ortho Pharmaceutical Corp
Original Assignee
Ortho Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharmaceutical Corp filed Critical Ortho Pharmaceutical Corp
Application granted granted Critical
Publication of ES2058280T3 publication Critical patent/ES2058280T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/56—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
    • C07C45/57—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom
    • C07C45/59—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom in five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/82—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/88—Unsaturated compounds containing keto groups containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C62/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C62/18—Saturated compounds containing keto groups
    • C07C62/22—Saturated compounds containing keto groups polycyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C62/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C62/30—Unsaturated compounds
    • C07C62/38—Unsaturated compounds containing keto groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/32—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups
    • C07C65/34—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups polycyclic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

SE DESCUBREN (1'',5''-DIARIL-3''-PIRAZOLIL)-N-HIDROXIPROPANAMIDAS 2- Y 3- SUSTITUIDAS, UN METODO PARA SU PREPARACION Y SU USO. LA N-HIDROXIPROPANAMIDAS SON UTILES PARA ALIVIAR LOS DESORDENES INFLAMATORIOS Y CARDIOVASCULARES EN MAMIFEROS.
ES88304821T 1987-05-29 1988-05-27 (1',5'-diaril-3-pirazolil)-n-hidroxipropanamidas 2-y 3-sustituidas farmacologicamente activas y procedimiento para su sintesis. Expired - Lifetime ES2058280T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5580687A 1987-05-29 1987-05-29
US18103588A 1988-04-27 1988-04-27

Publications (1)

Publication Number Publication Date
ES2058280T3 true ES2058280T3 (es) 1994-11-01

Family

ID=26734641

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88304821T Expired - Lifetime ES2058280T3 (es) 1987-05-29 1988-05-27 (1',5'-diaril-3-pirazolil)-n-hidroxipropanamidas 2-y 3-sustituidas farmacologicamente activas y procedimiento para su sintesis.

Country Status (9)

Country Link
EP (1) EP0293220B1 (es)
JP (2) JP2668796B2 (es)
AT (1) ATE110717T1 (es)
AU (1) AU611437B2 (es)
CA (2) CA1319149C (es)
DE (1) DE3851258T2 (es)
DK (1) DK289988A (es)
ES (1) ES2058280T3 (es)
IE (1) IE65095B1 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE59813B1 (en) * 1986-05-09 1994-04-06 Warner Lambert Co Styryl pyrazoles, isoxazoles and analogs thereof having activity as 5-lipoxy-genase inhibitors and pharmaceutical compositions containing them
DE3907180A1 (de) * 1989-03-06 1990-09-13 Windmoeller & Hoelscher Verfahren zum ueberpruefen der funktionsfaehigkeit von mit kuehlabschnitten versehenen extrusionsduesen von kunststoffextrudern zur herstellung von flach- oder schlauchfolien
PH27357A (en) * 1989-09-22 1993-06-21 Fujisawa Pharmaceutical Co Pyrazole derivatives and pharmaceutical compositions comprising the same
GB9005028D0 (en) * 1990-03-06 1990-05-02 Sandoz Ltd Improvements in or relating to organic compounds
US5117054A (en) * 1991-09-26 1992-05-26 Ortho Pharmaceutical Corporation N-hydroxy, N-methyl propanamides
IL104311A (en) * 1992-02-05 1997-07-13 Fujisawa Pharmaceutical Co Pyrazole derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
FR2692575B1 (fr) * 1992-06-23 1995-06-30 Sanofi Elf Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
AU3815495A (en) * 1994-11-08 1996-05-31 Eisai Co. Ltd. Pyrazole derivatives exhibiting anti-inflammatory and analgesic effects
EP0833622B8 (en) * 1995-06-12 2005-10-12 G.D. Searle & Co. Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor
CA2460149A1 (en) * 2001-09-12 2003-03-27 Kaken Pharmaceutical Co., Ltd. 2-phenyl-3-heteroarylpropionic acid derivative or salt thereof and medicine containing the same
UA79804C2 (en) 2002-07-03 2007-07-25 Janssen Pharmaceutica Nv Cck-1 receptor modulators
US7640164B2 (en) 2002-07-04 2009-12-29 Denso Corporation System for performing interactive dialog
WO2004037793A1 (ja) * 2002-10-24 2004-05-06 Wakamoto Pharmaceutical Co., Ltd. シクロオキシゲナーゼ及び５−リポキシゲナーゼを阻害するピラゾール−４−アルカン酸誘導体
US7129239B2 (en) 2002-10-28 2006-10-31 Pfizer Inc. Purine compounds and uses thereof
US7247628B2 (en) 2002-12-12 2007-07-24 Pfizer, Inc. Cannabinoid receptor ligands and uses thereof
US7329658B2 (en) 2003-02-06 2008-02-12 Pfizer Inc Cannabinoid receptor ligands and uses thereof
US7176210B2 (en) 2003-02-10 2007-02-13 Pfizer Inc. Cannabinoid receptor ligands and uses thereof
US7268133B2 (en) 2003-04-23 2007-09-11 Pfizer, Inc. Patent Department Cannabinoid receptor ligands and uses thereof
US7145012B2 (en) 2003-04-23 2006-12-05 Pfizer Inc. Cannabinoid receptor ligands and uses thereof
WO2005063716A1 (en) 2003-12-22 2005-07-14 Janssen Pharmaceutica, N.V. Imidazoles and their use cck-1 receptor modulators
US20130164226A1 (en) * 2010-09-10 2013-06-27 Daizo Corporation Foamable aerosol composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE755924A (fr) * 1969-09-12 1971-02-15 Byk Gulden Lomberg Chem Fab Derives d'acide pyrazole-4-acetique, leur procede de preparation et medicaments en contenant
DE2633992A1 (de) * 1975-08-08 1978-02-09 Schering Ag Neue pyrazol-derivate, ihre herstellung und verwendung
EP0014508B1 (en) * 1979-02-09 1983-06-08 Shell Internationale Researchmaatschappij B.V. Process for the preparation of colour stabilised vinyl chloride polymers
DE2906252A1 (de) * 1979-02-19 1980-08-28 Merck Patent Gmbh Pyrazolderivate, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung
JPS5699254A (en) * 1980-01-14 1981-08-10 Adeka Argus Chem Co Ltd Stabilized halogen-containing resin composition
JPS60190708A (ja) * 1984-03-12 1985-09-28 Kao Corp 長波長紫外線吸収剤
JPS61140543A (ja) * 1984-12-11 1986-06-27 Kao Corp ４−メトキシ−２′−カルボキシジベンゾイルメタンおよびその塩
JPS6259243A (ja) * 1985-09-10 1987-03-14 Kao Corp ２−カルボキシジベンゾイルメタン類の製造法
US4694018A (en) * 1985-11-29 1987-09-15 G. D. Serale & Co. Substituted 1,5-diphenyl-2-pyrrolepropionic acids and derivatives
US4826868A (en) * 1986-05-29 1989-05-02 Ortho Pharmaceutical Corporation 1,5-Diaryl-3-substituted pyrazoles pharmaceutical compositions and use

Also Published As

Publication number Publication date
IE881612L (en) 1988-11-29
JPH09328475A (ja) 1997-12-22
CA1341424C (en) 2003-03-04
EP0293220A2 (en) 1988-11-30
DE3851258D1 (de) 1994-10-06
ATE110717T1 (de) 1994-09-15
DE3851258T2 (de) 1994-12-15
CA1319149C (en) 1993-06-15
JP2668796B2 (ja) 1997-10-27
DK289988D0 (da) 1988-05-27
AU1657488A (en) 1988-12-01
IE65095B1 (en) 1995-10-04
EP0293220A3 (en) 1990-07-11
JP2848375B2 (ja) 1999-01-20
EP0293220B1 (en) 1994-08-31
AU611437B2 (en) 1991-06-13
JPS6452758A (en) 1989-02-28
DK289988A (da) 1988-11-30

Similar Documents

Publication Publication Date Title
ES2058280T3 (es) (1',5'-diaril-3-pirazolil)-n-hidroxipropanamidas 2-y 3-sustituidas farmacologicamente activas y procedimiento para su sintesis.
EP0161877A3 (en) 1,4-dihydropyridine derivatives, methods for their production and pharmaceutical compositions comprising the same
MY131298A (en) 5-heteroyl indole derivatives
EP0181837A3 (en) Polyimides, process for their preparation, and their use, and tetracarboxylic acids and tetracarboxylic acid derivatives
HUT37418A (en) Process for producing new 2,2'-imino-bis/ethanol/ derivatives and pharmaceutical compositions sontaining them as active agents
NO831679L (no) Fremgangsmaate for fremstilling av farmakologisk aktive 1,3-dioksan-5-yl-alkensyrer
ATE40365T1 (de) 3-acylaminomethylimidazo (1,2-a> pyridine, dessen herstellung und therapeutische anwendung.
IT1187717B (it) Procedimento per la preparazione di derivati 3-sostituiti dell'1-amino-2-idrossi-propano
AU567186B2 (en) Tar and linolenic acid topical preparation
MW185A1 (en) 1,3-disubstituted oxindoles as analgesic and anti-inflammatory agents
GB2156808B (en) 2- or 2,3-substituted 5,6,11,12-tetrathiotetracene and 5,6,11,12-tetraselenotetracene, process for their preparation, and their use
PL319455A1 (en) Derivatives of colchicine and their tharapeutic application
SE7702041L (sv) Forfarande for framstellning av 2,3-substituerade, 5,6-kondenserade 4(2h)-aminoalkoxi-pyranoner med hypotensiv, anti-ischemi-och antihostverkan
PT84339A (pt) 1,6-naphthyridine derivatives process for the preparation thereof and pharmaceutical compositions containing them
AU5842886A (en) 1,4-dihydropyridine derivatives useful for the treatment of cardiovascular disorders
ATE19855T1 (de) Pharmazeutische und diaetetische zusammensetzung.
ES557423A0 (es) Procedimiento para la preparacion de derivados de 1,4-dihidropiridina
JPS6416755A (en) Manufacture of n-(3',4'-dimethoxycinnamoyl)-aniline derivative
AU7189991A (en) New derivatives of 1,3,5-triamino-2,4,6-triiodobenzene and method for the preparation thereof
ZA863914B (en) 1,4-dihydropyridine derivatives useful for the treatment of cardiovascular disorders
ZA883831B (en) Pharmacologically active 2-and 3-substituted(1',5'-diaryl-3-pyrazolyl)-n-hydroxypropanamides and method for synthesizing the same
IT1199830B (it) 10 b-alchinil-4,9(11)-estradiene derivati e procedimento per la loro preparazione
IL74251A (en) 1,3-disubstituted oxindoles and analgesic and antiinflammatory compositions comprising them
IT1193371B (it) 11-(2'-imidazol-1''-il)-acetil-5,11-diidro-6h-pirido 2,3-b 1,4 benzodiazepin-6-oni,metodo per la loro preparazione e la loro applicazione nella terapia dell'ulcera
MX174139B (es) Composiciones y metodo para tratamiento de glaucoma por la administracion topica de t-butilamino-3-(4-morfolin-1,2,5-tiadiazol-3-iloxi-2-propanol,hidrogeno maleato

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 293220

Country of ref document: ES